Assura Plc
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices and has a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's portf… Read more
Assura Plc (ARSSF) - Net Assets
Latest net assets as of March 2025: $1.64 Billion USD
Based on the latest financial reports, Assura Plc (ARSSF) has net assets worth $1.64 Billion USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.28 Billion) and total liabilities ($1.64 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.64 Billion |
| % of Total Assets | 50.05% |
| Annual Growth Rate | 13.23% |
| 5-Year Change | 7.3% |
| 10-Year Change | 117.74% |
| Growth Volatility | 39.04 |
Assura Plc - Net Assets Trend (2005–2025)
This chart illustrates how Assura Plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Assura Plc (2005–2025)
The table below shows the annual net assets of Assura Plc from 2005 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $1.64 Billion | +11.49% |
| 2024-03-31 | $1.47 Billion | -7.21% |
| 2023-03-31 | $1.59 Billion | -11.29% |
| 2022-03-31 | $1.79 Billion | +16.91% |
| 2021-03-31 | $1.53 Billion | +17.53% |
| 2020-03-31 | $1.30 Billion | +1.76% |
| 2019-03-31 | $1.28 Billion | +2.36% |
| 2018-03-31 | $1.25 Billion | +52.86% |
| 2017-03-31 | $818.00 Million | +8.44% |
| 2016-03-31 | $754.30 Million | +66.92% |
| 2015-03-31 | $451.90 Million | +99.43% |
| 2014-03-31 | $226.60 Million | +14.39% |
| 2013-03-31 | $198.10 Million | +5.43% |
| 2012-03-31 | $187.90 Million | -14.64% |
| 2011-03-31 | $220.13 Million | +35.31% |
| 2010-03-31 | $162.68 Million | -5.43% |
| 2009-03-31 | $172.02 Million | -35.18% |
| 2008-03-31 | $265.38 Million | -0.79% |
| 2007-03-31 | $267.50 Million | +126.83% |
| 2006-03-31 | $117.93 Million | -13.76% |
| 2005-03-31 | $136.75 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Assura Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 7350000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $73.50 Million | 4.48% |
| Common Stock | $325.10 Million | 19.79% |
| Other Components | $1.24 Billion | 75.73% |
| Total Equity | $1.64 Billion | 100.00% |
Assura Plc Competitors by Market Cap
The table below lists competitors of Assura Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Texwinca Holdings Limited
PINK:TXWHY
|
$161.66 Million |
|
Kontour (Xi'an) Medical Technology Co. Ltd.
SHG:688314
|
$161.68 Million |
|
Beijing JCZ Technology Co. Ltd. A
SHG:688291
|
$161.75 Million |
|
Ranpak Holdings Corp
NYSE:PACK
|
$161.75 Million |
|
Jiangsu Hengxing New Material
SHG:603276
|
$161.58 Million |
|
Eastern Media International Corp
TW:2614
|
$161.55 Million |
|
WhiteFiber, Inc. Ordinary Shares
NASDAQ:WYFI
|
$161.52 Million |
|
PharmaEngine
TWO:4162
|
$161.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Assura Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,473,100,000 to 1,642,400,000, a change of 169,300,000 (11.5%).
- Net income of 166,000,000 contributed positively to equity growth.
- Dividend payments of 93,300,000 reduced retained earnings.
- Other comprehensive income decreased equity by 231,000,000.
- Other factors increased equity by 327,600,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $166.00 Million | +10.11% |
| Dividends Paid | $93.30 Million | -5.68% |
| Other Comprehensive Income | $-231.00 Million | -14.06% |
| Other Changes | $327.60 Million | +19.95% |
| Total Change | $- | 11.49% |
Book Value vs Market Value Analysis
This analysis compares Assura Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.19x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.66x to 1.19x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-03-31 | $0.94 | $0.62 | x |
| 2006-03-31 | $0.80 | $0.62 | x |
| 2007-03-31 | $1.30 | $0.62 | x |
| 2008-03-31 | $1.13 | $0.62 | x |
| 2009-03-31 | $0.65 | $0.62 | x |
| 2010-03-31 | $0.50 | $0.62 | x |
| 2011-03-31 | $0.67 | $0.62 | x |
| 2012-03-31 | $0.41 | $0.62 | x |
| 2013-03-31 | $0.37 | $0.62 | x |
| 2014-03-31 | $0.43 | $0.62 | x |
| 2015-03-31 | $0.58 | $0.62 | x |
| 2016-03-31 | $0.58 | $0.62 | x |
| 2017-03-31 | $0.50 | $0.62 | x |
| 2018-03-31 | $0.64 | $0.62 | x |
| 2019-03-31 | $0.54 | $0.62 | x |
| 2020-03-31 | $0.54 | $0.62 | x |
| 2021-03-31 | $0.57 | $0.62 | x |
| 2022-03-31 | $0.61 | $0.62 | x |
| 2023-03-31 | $0.54 | $0.62 | x |
| 2024-03-31 | $0.50 | $0.62 | x |
| 2025-03-31 | $0.52 | $0.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Assura Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.11%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 90.32%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 2.00x
- Recent ROE (10.11%) is above the historical average (-0.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 1.63% | 59.36% | 0.03x | 1.02x | $-11.45 Million |
| 2006 | -10.58% | -178.15% | 0.04x | 1.39x | $-24.31 Million |
| 2007 | 7.06% | 117.22% | 0.05x | 1.23x | $-7.86 Million |
| 2009 | -63.16% | -228.63% | 0.10x | 2.69x | $-125.98 Million |
| 2010 | -5.34% | -15.57% | 0.12x | 2.83x | $-24.95 Million |
| 2011 | 6.85% | 24.26% | 0.10x | 2.87x | $-6.94 Million |
| 2012 | -32.30% | -178.01% | 0.06x | 3.17x | $-79.49 Million |
| 2013 | 7.12% | 38.01% | 0.06x | 3.17x | $-5.71 Million |
| 2014 | 15.45% | 87.72% | 0.06x | 3.15x | $12.34 Million |
| 2015 | 8.23% | 72.80% | 0.05x | 2.23x | $-7.99 Million |
| 2016 | 3.70% | 45.74% | 0.05x | 1.54x | $-47.53 Million |
| 2017 | 11.65% | 134.04% | 0.05x | 1.69x | $13.50 Million |
| 2018 | 5.74% | 85.99% | 0.05x | 1.43x | $-53.24 Million |
| 2019 | 6.56% | 82.03% | 0.05x | 1.59x | $-43.99 Million |
| 2020 | 6.06% | 70.76% | 0.05x | 1.70x | $-51.34 Million |
| 2021 | 7.08% | 89.65% | 0.05x | 1.67x | $-44.77 Million |
| 2022 | 8.71% | 113.88% | 0.04x | 1.74x | $-23.06 Million |
| 2023 | -7.51% | -79.26% | 0.05x | 1.84x | $-277.95 Million |
| 2024 | -1.96% | -18.25% | 0.06x | 1.91x | $-176.11 Million |
| 2025 | 10.11% | 90.32% | 0.06x | 2.00x | $1.76 Million |
Industry Comparison
This section compares Assura Plc's net assets metrics with peer companies in the REIT - Healthcare Facilities industry.
Industry Context
- Industry: REIT - Healthcare Facilities
- Average net assets among peers: $965,116,889
- Average return on equity (ROE) among peers: 3.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Assura Plc (ARSSF) | $1.64 Billion | 1.63% | 1.00x | $161.63 Million |
| Aedifica SA (AEDFF) | $193.91 Million | 7.53% | 0.90x | $2.97 Billion |
| American Healthcare REIT, Inc. (AHR) | $1.65 Billion | -4.93% | 1.90x | $9.31 Billion |
| Cofinimmo SA/NV (CFMOF) | $2.65 Billion | 4.50% | 0.98x | $2.38 Billion |
| Community Healthcare Trust Inc (CHCT) | $496.81 Million | 4.43% | 0.76x | $419.21 Million |
| CareTrust REIT Inc. (CTRE) | $1.42 Billion | 3.79% | 0.47x | $8.79 Billion |
| Chartwell Retirement Residences (CWSRF) | $509.23 Million | 4.69% | 4.57x | $3.84 Billion |
| Healthpeak Properties Inc (DOC) | $264.20 Million | 5.22% | 0.63x | $11.75 Billion |
| Global Medical REIT Inc. (GMRE) | $460.35 Million | 2.01% | 0.92x | $440.68 Million |
| Healthcare Realty Trust Incorporated (HR) | $1.04 Billion | 8.24% | 0.54x | $6.10 Billion |